12.99

8.16% 0.98

Pre-market: 13.45 0.46 +3.54%

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $12.99, with a volume of 1.31M. It is up +8.16% in the last 24 hours and down -10.91% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$12.01

Open:

$12.13

24h Volume:

1.31M

Relative Volume:

0.82

Market Cap:

$611.69M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-1.00

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

-4.27%

1M Performance:

-10.91%

6M Performance:

+76.26%

1Y Performance:

+70.47%

1-Day Range:

$12.10

$13.18

1-Week Range:

$11.83

$13.75

52-Week Range:

$5.00

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	12.99	710.99M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

03:32 AM

Ginkgo Bioworks Holdings Inc. stock daily chart insightsEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com

03:32 AM

01:09 AM

Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockJuly 2025 Short Interest & AI Driven Stock Reports - newser.com

01:09 AM

Nov 02, 2025

Live market analysis of Ginkgo Bioworks Holdings Inc.2025 Stock Rankings & Safe Entry Trade Reports - newser.com

Nov 02, 2025

Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainableQuarterly Trade Review & High Win Rate Trade Tips - newser.com

Nov 02, 2025

Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Nov 02, 2025

Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strengthBear Alert & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025

Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat

Nov 02, 2025

Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declines2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com

Nov 02, 2025

Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 01, 2025